Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-009928

President and CEO sold 21,000 shares at $18.92 ($397,320)

  • President and CEO acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Grossman Adam S President and CEO 2025-03-19 Option exercise 10b5-1 +15,000 $5.40 $81,000 2,082,850 D: show line 1 in the form
Grossman Adam S President and CEO 2025-03-19 Sale 10b5-1 −15,000 $18.92 $283,800 2,067,850 D: show line 2 in the form
Grossman Adam S President and CEO 2025-03-19 Sale 10b5-1 −6,000 $18.92 $113,520 2,061,850 D: show line 3 in the form
Open-market sales · 21,000 sh · avg $18.92 · $397,320

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Grossman Adam S President and CEO 2025-03-19 Option exercise · Common Stock 10b5-1 −15,000 855,950 D: show line 4 in the form
Loading xslF345X05/form4.xml…